Release Date: 31/10/14 17:10 Summary: Quarterly Cashflow Report Price Sensitive: No Download Document 110.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%